This hormone is naturally produced in the intestines and plays a crucial role in regulating blood sugar levels and appetite
To view a copy of this licence, visit About this article Cite this article Huang, CY., Chung, YH., Wu, SY
Farxiga (Dapagliflozin) Farxiga sales in 2022: $4.381 billion Company/Developer: AstraZeneca Date of first FDA approval: January 8, 2014 Indications Farxiga is FDA-approved for: Type 2 diabetes, reducing risk of heart failure, chronic kidney disease (regardless of diabetic status) Price of Farxiga: About $623 for a supply of 30 oral 10 mg tablets Why it did so well: Farxiga is a SGLT2 inhibitor used primarily for the treatment of type 2 diabetes
If you have questions about how CGM data integrates with peptide therapy monitoring, Meto's article on CGM and Peptide Therapy: Why Continuous Glucose Monitoring Changes Everything About Tracking Your Response is directly relevant to this
Such flexibility surpasses fixed-dose combination drugs by introducing responsiveness to real-time patient status